Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025Sidley Represents JOLT in its Agreement to Acquire Assets from Volta Media NetworkDecember 10, 2025Sidley Represents Jane Street in Investments in Kraken and X-EnergyDecember 3, 2025Sidley Represents Nuvalent in Pricing of US$500 Million Public OfferingNovember 20, 2025Sidley Represents RA Capital Management in Artios Pharma’s US$115 million Series D FundingNovember 20, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory